ライフサイエンスコーパス: neuroectodermal tumor

1 al teratoid/rhabdoid tumor and CNS primitive neuroectodermal tumor).

2 of the chest wall, and peripheral primitive neuroectodermal tumor.

3 stoma, choroid plexus carcinoma, and primary neuroectodermal tumor.

4 the neuroblastic rosettes in human primitive neuroectodermal tumors.

5 neuroblastomas to Ewing's sarcoma/peripheral neuroectodermal tumors.

6 nificantly, CD155 is aberrantly expressed in neuroectodermal tumors.

7 g development and the expression of CD155 in neuroectodermal tumors.

8 nt of Ewing's sarcoma and related peripheral neuroectodermal tumors.

9 also thought to be etiological in primitive neuroectodermal tumors.

10 anslocation in Ewing's sarcoma and primitive neuroectodermal tumors.

11 creaticoblastomas and 1 of 10 with primitive neuroectodermal tumors.

12 eleted in neuroblastoma, melanoma, and other neuroectodermal tumors.

13 mmon mechanism in the causation of primitive neuroectodermal tumors.

14 Among sarcomas, 21 of 21 Ewing's/primitive neuroectodermal tumor, 28 of 29 rhabdomyosarcomas, 28 of

15 g of treatment: medulloblastoma or primitive neuroectodermal tumors, 57.8; germ cell tumors, 63.5; ep

16 Ganglioside GD2 is highly expressed on neuroectodermal tumors and an attractive therapeutic tar

17 as found to be overexpressed in a variety of neuroectodermal tumors and described as an essential ang

18 involved in Ewing sarcoma, related primitive neuroectodermal tumors and desmoplastic small round cell

19 se (PR) in two patients with Ewing/primitive neuroectodermal tumors and included one PR and one minor

20 eosarcomas, one Ewing sarcoma, one primitive neuroectodermal tumor, and one desmoplastic small round

21 of gliomas, central nervous system primitive neuroectodermal tumors, and atypical teratoid/rhabdoid-l

22 blastomas (MBs) and supratentorial primitive neuroectodermal tumors, and we report the outcome in the

23 ise Ewing's sarcoma and peripheral primitive neuroectodermal tumors, are highly aggressive and mostly

24 multilayered rosettes (ETMRs) are primitive neuroectodermal tumors arising in infants.

25 hed GEM models of medulloblastoma, primitive neuroectodermal tumor, astrocytoma, oligodendroglioma, m

26 rentiated sarcoma, and soft tissue primitive neuroectodermal tumor at all sites except paratesticular

27 y SCLC cultures as well as in some primitive neuroectodermal tumor biopsies.

28 as, and cell lines derived from a variety of neuroectodermal tumors by Northern analysis and in situ

29 Using a human peripheral primitive neuroectodermal tumor cell line, SK-N-MC, we demonstrate

30 Neuroectodermal tumor cell lines derived from other site

31 The GD2 ganglioside expressed on neuroectodermal tumor cells has been used as a target fo

32 TF4 mediates ER stress-induced cell death of neuroectodermal tumor cells in response to fenretinide o

33 strates, in contrast to cells from primitive neuroectodermal tumors cells (n=6), which only migrated

34 ade glioma, 32 had medulloblastoma/primitive neuroectodermal tumor/embryonal tumor, 17 had malignant

35 or medulloblastoma, supratentorial primitive neuroectodermal tumor, ependymoma, and rhabdoid tumors,

36 s of patients with Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) metastatic to bone/bone

37 Ewings sarcoma and primitive neuroectodermal tumors (ES/PNET) are characterized by th

38 Primary renal primitive neuroectodermal tumor/extraskeletal Ewing's sarcoma (PNE

39 allmark of the Ewing's sarcoma and primitive neuroectodermal tumor family, encodes a fusion protein w

40 ingle cell type (two patients with primitive neuroectodermal tumors, five with undifferentiated RMS,

41 with pathology consistent with grade III-IV neuroectodermal tumors in mice.

42 uld raise the suspicion of a renal primitive neuroectodermal tumor, in a young adult.

43 evidence for the development of inheritable neuroectodermal tumors induced by the human polyomavirus

44 One hallmark of Ewing's sarcoma/peripheral neuroectodermal tumors is the presence of the Ews/Fli-1

45 gene found in Ewing's sarcoma and primitive neuroectodermal tumor, is able to transform certain cell

46 ntaining tumors, brain lymphoma or primitive neuroectodermal tumor make use of systemic administratio

47 Since primitive neuroectodermal tumors/medulloblastomas (PNETs/medullobl

48 foci of yolk sac tumor (n = 21) or primitive neuroectodermal tumor (n = 2), whereas 50 had pure immat

49 pendymoma (n = 8), medulloblastoma/primitive neuroectodermal tumor (n = 4), glioblastoma multiforme (

50 m glioma (n = 7), medulloblastoma/peripheral neuroectodermal tumor (n = 6), ependymoma (n = 3), and p

51 The neuroectodermal tumors neuroblastoma and melanoma repres

52 ithout a bone sarcoma (ie, neither primitive neuroectodermal tumor nor osteosarcoma) (HR for PFS, 0.3

53 Ewing's sarcoma and primitive neuroectodermal tumor of bone are closely related, highl

54 n patients with Ewing's sarcoma or primitive neuroectodermal tumor of bone who had a relapse after st

55 ith nonmetastatic Ewing's sarcoma, primitive neuroectodermal tumor of bone, or primitive sarcoma of b

56 d or younger with Ewing's sarcoma, primitive neuroectodermal tumor of bone, or primitive sarcoma of b

57 Primitive neuroectodermal tumors of the central nervous system (CN

58 or = 30 years with Ewing sarcoma, primitive neuroectodermal tumor or primitive sarcoma of bone were

59 ren treated for medulloblastoma or primitive neuroectodermal tumor (PNET) and document the associated

60 of Ewing's Sarcoma and peripheral Primitive Neuroectodermal Tumor (PNET) are associated with aberran

61 Medulloblastoma (MB) and primitive neuroectodermal tumor (PNET) are histologically similar

62 imaging of brain involvement with primitive neuroectodermal tumor (PNET) demonstrated mild hypometab

63 the Ewing sarcoma (ES)/peripheral primitive neuroectodermal tumor (PNET) family are pediatric cancer

64 with metastatic Ewing's sarcoma or primitive neuroectodermal tumor (PNET) of bone were entered onto a

65 loblastoma, central nervous system primitive neuroectodermal tumor (PNET), and astrocytoma before 6 y

66 medulloblastoma or supratentorial primitive neuroectodermal tumor (PNET).

67 c patients with medulloblastoma or primitive neuroectodermal tumor (PNET).

68 Ten of 20 (50%) patients (primitive neuroectodermal tumor (PNET)/medulloblastoma, three pati

69 genic (OS) and Ewing's (ES) and/or primitive neuroectodermal tumor (PNET)] sarcoma, treated with chem

70 ma and 158 children diagnosed with primitive neuroectodermal tumors (PNET) in the United States and C

71 loped bilateral retinoblastoma and primitive neuroectodermal tumors (PNET) of the midbrain.

72 such as Ewing's sarcoma (EWS) and primitive neuroectodermal tumors (PNET), are highly aggressive mal

73 mice to the human medulloblastoma/primitive neuroectodermal tumor (PNETs) in location, histologic ap

74 Primitive neuroectodermal tumors (PNETs) are a family of primary m

75 Primitive neuroectodermal tumors (PNETs) of the central nervous sy

76 Primitive neuroectodermal tumors (PNETs) of the central nervous sy

77 ions in medulloblastomas and other primitive neuroectodermal tumors (PNETs) of the childhood CNS we p

78 (HASH1) in cerebellar and cerebral primitive neuroectodermal tumors (PNETs), gliomas, and cell lines

79 s to the development of cerebellar primitive neuroectodermal tumors (PNETs).

80 neuroblastoma, pineoblastoma, and primitive neuroectodermal tumors (PNETs).

81 rade glioma and in two of six with primitive neuroectodermal tumors (PNETs)/ medulloblastoma.

82 PR) in one patient with peripheral primitive neuroectodermal tumor (PPNET), and a minimal response (M

83 We have analyzed a primitive neuroectodermal tumor sample exhibiting loss of heterozy

84 lly Ewing's sarcoma and peripheral primitive neuroectodermal tumor, share a common class of tumor-spe

85 hereas experimental supratentorial primitive neuroectodermal tumors (sPNET) correspond to atypical te

86 of a panel of human supratentorial primitive neuroectodermal tumors (sPNET) showed low activity of th

87 and Type II) are differentially expressed in neuroectodermal tumor tissue relative to differentiated

88 a new approach to the treatment of primitive neuroectodermal tumors we evaluated the effect of the HM

89 tem NSCs generated medulloblastoma/primitive neuroectodermal tumors, whereas forebrain NSCs developed

90 ic animals that develop cerebellar primitive neuroectodermal tumors which model human medulloblastoma

91 ansformed with N-Myc, we generated primitive neuroectodermal tumors with divergent differentiation in